Some clinical trials aren't designed to answer scientific questions. They're designed to market drugs. In our recently ...

Clinical trials are the irreplaceable engine of drug development and a bedrock of modern medicine, yet patient enrollment ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with ...

The clinical trial landscape is continually adapting its focus on patient-centric practices to improve clinical trial participation by reducing patients' burden. Over the past few years, this shift ...

Clinical trial names span a broad range, from straightforward acronyms to more inspiring titles—see: Eli Lilly’s optimistically dubbed family of Triumph trials—to the downright ostentatious, like ...

Women were generally excluded from clinical trials until the 1990s; in 1993, the NIH inclusion policy was codified into ...

When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...

BOSTON, May 07, 2026--eClinical Solutions LLC, a global provider of digital clinical software and services, today announced ...

U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of ...

Investigators found an association between political ideology and clinical trial skepticism, with conservative identification corresponding to higher odds of trial skepticism.